熱門資訊> 正文

Kyverna Therapeutics宣布拟公开募股1亿美元

2025-12-16 05:40

Kyverna Therapeutics, Inc.(KYTX) 0
摩根士丹利(MS) 0

Kyverna Therapeutics (NASDAQ:KYTX) announced on Monday that it has commenced an underwritten public offering of $100M of shares, and underwriters will be granted a 30-day option to purchase up to an additional $15M of shares of common stock at the public offering price.
J.P. Morgan, Leerink Partners, Morgan Stanley, and Wells Fargo Securities are acting as joint book-running managers for the offering.
The securities will be offered pursuant to a shelf registration statement filed with the SEC on March 27, 2025, and declared effective on April 15, 2025.
Shares +23.23%.

More on Kyverna Therapeutics

Kyverna Therapeutics: Miv-Cel Delivers Breakthrough Data In Stiff Person Syndrome
Kyverna Therapeutics: Immune Reset Is Clinically Validated, Market Ignores Potential
Seeking Alpha’s Quant Rating on Kyverna Therapeutics
Historical earnings data for Kyverna Therapeutics
Financial information for Kyverna Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。